Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuits
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
The step was taken after Health Canada learned that an active ingredient was made in a Baltimore plant with contamination problems.
Copyright © 2024 | WordPress Theme by MH Themes